Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit used for detecting brain glioma gene mutation, and preparation method

A glioma and detection reagent technology, applied in biochemical equipment and methods, microbial determination/inspection, etc., can solve problems such as poor prognosis, low possibility of surgery and biopsy, and achieve the effect of ensuring specificity

Pending Publication Date: 2021-02-23
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinical research practice shows that spinal cord dissemination mostly occurs in the late stage of the disease. Once spinal cord dissemination occurs, the prognosis of patients is poor. At present, leptomeningospinal metastasis is mainly based on imaging examination. Less likely, there is no clear molecular spectrum and better clinical cytology pathological diagnosis method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] 1) Formulate the inclusion criteria, exclusion criteria, and termination criteria for subjects;

[0054] 2) Calculate the number of cases required to achieve the expected purpose of the research according to statistical principles;

[0055] 3) Experimental process:

[0056] Step 1 Collection of samples: For patients with clinically suspected initial or recurrent glioma, collect CSF samples from lumbar puncture or cerebrospinal fluid drainage to detect the remaining discarded cerebrospinal fluid, about 3-5ml. At the same time, 3-4ml of blood was collected, and 1 piece of brain paraffin tissue was collected from the surgical patient (the remaining paraffin section after the surgical pathological section of the patient is more than 2cm, and the normal reserved sample has been guaranteed to be used for review);

[0057] Step 2 Detection process: Pretreatment of cerebrospinal fluid and plasma samples: cerebrospinal fluid, plasma supernatant and buffy coat were obtained by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the biotechnology field, and relates to a cerebrospinal fluid liquid state biopsy technology and a kit preparation method thereof, in particular to a detection kit for dynamically monitoring change of ctDNA in the cerebrospinal fluid of a glioma patient through detection of hotspot gene mutation, and a preparation method of the detection kit. The invention mainly takes brain glioma and meningioma as detection objects, on the basis of a high-throughput gene sequencing detection method, the change of the ctDNA in the cerebrospinal fluid of the glioma patient and a meningioma patient, and main mutation genes related to the glioma and the meningioma are screened to establish a liquid state biopsy gene kit. Through dynamic monitoring of the gene change of the glioma patient before / after an operation, radiotherapy and chemotherapy, a gene-oriented glioma molecular diagnosis, including minimal residual disease surgical excision, pseudoprogression or recurrence, is carried out, and reaction for the radiotherapy and the chemotherapy and change of drug tolerance are monitored.

Description

technical field [0001] The invention belongs to the field of biological technology, and relates to a cerebrospinal fluid liquid biopsy technique and a preparation method thereof, in particular to a detection kit and a preparation method for dynamically monitoring ctDNA changes in the cerebrospinal fluid of glioma patients by detecting hotspot gene mutations. Background technique [0002] The prior art discloses advances in dynamic, low-invasive liquid biopsy detection of circulating DNA, RNA, or circulating tumor cells of tumor origin, e.g. Rhodes et al. (1994) detected a tumor in the cerebrospinal fluid of a patient with glioma Specific P53 gene mutation. Yuxuan Wang et al. (2015) performed targeted sequencing or whole-genome sequencing on 35 cases of primary central nervous system malignancies, and found that all medulloblastoma, ependymoma, and high-grade glioma near the cerebrospinal fluid space could be detected. at least one mutation. Changcun Pan et al. (2018) Chine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886
CPCC12Q1/6886C12Q2600/156C12Q2600/118C12Q2600/106
Inventor 张弢刘琴丁耀东
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products